Dinesh Kumar Kesavan

Identification of Natural Compound Inhibitors for Multidrug Efflux Pumps of Escherichia coli and Pseudomonas aeruginosa Using In Silico High-Throughput Virtual Screening and In Vitro Validation

Aparna Vasudevan, Dinesh Kumar Kesavan, Narasumani Mohanalakshmi et al. · PLoS ONE · 2014 · 145 citations · Full text

Engineering, Escherichia Coli, Antimicrobial Chemotherapy +20

Pterostilbene-mediated Nrf2 activation: Mechanistic insights on Keap1:Nrf2 interface

Elango Bhakkiyalakshmi, Dinesh Kumar Kesavan, Suresh Karthik et al. · Bioorganic & Medicinal Chemistry · 2016 · 91 citations

Pterostilbene-mediated Nrf2 Activation, Reductive Stress, Signal Transduction +6

Antimicrobial Susceptibility Profile of Extended Spectrum β-Lactamase (ESBL) Producing <i>Escherichia coli</i> from Various Clinical Samples

Dinesh Kumar Kesavan, Amit Kumar Singh, Mohammad Rashid Ali et al. · Infectious Diseases Research and Treatment · 2014 · 67 citations · Full text

ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+ T cells

Jie Wan, Yinqiu Wu, Lan Huang et al. · Cancer Letters · 2021 · 47 citations

Inflammation, Cancer Immunosurveillance, Immunology +5

Integrative analysis of outer membrane vesicles proteomics and whole-cell transcriptome analysis of eravacycline induced Acinetobacter baumannii strains

Dinesh Kumar Kesavan, Aparna Vasudevan, Liang Wu et al. · BMC Microbiology · 2020 · 44 citations · Full text